NCT04996316View on ClinicalTrials.gov

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

Enrolling by invitationOBSERVATIONAL
Enrollment

1,141

Participants

Timeline

Start Date

September 7, 2022

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Breast Carcinoma
Interventions
OTHER

Electronic Health Record Review

Health record reviewed

OTHER

Interview

Participate in interview

OTHER

Media Intervention

Use MammoScreen

OTHER

Survey Administration

Complete survey

OTHER

Training and Education

Undergo training

Trial Locations (1)

97239

OHSU Knight Cancer Institute, Portland

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

collaborator

Oregon Health and Science University

OTHER

lead

OHSU Knight Cancer Institute

OTHER